Clinical Trial Update: Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD) [Phase 3]

View source ↗

Summary

Phase 3 trial for venlafaxine extended-release in major depressive disorder completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Venlafaxine ER (venlafaxine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-03-13